Revenue Performance - Revenue for the three months ended December 31, 2021, was HKD 29,215,000, an increase of 22.5% compared to HKD 23,880,000 for the same period in 2020[5] - Revenue for the nine months ended December 31, 2021, was HKD 80,069,000, up 1.9% from HKD 78,588,000 in the same period of 2020[5] - For the three months ended December 31, 2021, the revenue from Chinese cuisine was HKD 6,167,000, an increase from HKD 5,446,000 in the same period of 2020, representing a growth of 13.2%[20] - The revenue from Thai cuisine for the nine months ended December 31, 2021, was HKD 19,268,000, down 14.4% from HKD 22,452,000 in the same period of 2020[20] - The revenue from Malaysian cuisine decreased to HKD 25,579,000 for the nine months ended December 31, 2021, a decline of 11.2% compared to HKD 28,757,000 in the same period of 2020[20] - The "Masaun Le/Masan Le" brand generated revenue of approximately HKD 18.6 million, accounting for 23.3% of total revenue, representing a decrease of 16.3% year-on-year due to a reduction in the number of restaurants and the negative impact of COVID-19[42] - The "Thai Lane" brand recorded revenue of approximately HKD 19.3 million, accounting for 24.1% of total revenue, with a year-on-year decrease of 14.2% attributed to similar factors[44] - The "Baba Nyonya" brand achieved revenue of approximately HKD 25.6 million, making up 31.9% of total revenue, reflecting an 11.1% decrease compared to the previous year[44] - The "Sales of Pharmaceutical Machines and Related Services" segment, established after the acquisition of Guoxing, generated revenue of approximately HKD 8.2 million, accounting for 10.2% of total revenue, with no prior year comparison available[45] - The "Sales of Ingredients" segment saw a revenue increase of 63.6% to approximately HKD 8.4 million, representing 10.5% of total revenue, driven by sales growth[44] Profit and Loss - The group reported a loss of HKD 1,108,000 for the three months ended December 31, 2021, compared to a profit of HKD 10,365,000 in the same period of 2020[7] - The loss attributable to owners of the company for the nine months ended December 31, 2021, was HKD 8,225,000, compared to a profit of HKD 8,161,000 for the same period in 2020[7] - Basic loss per share for the three months ended December 31, 2021, was HKD (0.12), compared to earnings of HKD 1.14 for the same period in 2020[7] - The group’s total comprehensive loss for the three months ended December 31, 2021, was HKD (1,022,000), compared to total comprehensive income of HKD 10,365,000 for the same period in 2020[5] - For the nine months ended December 31, 2021, the company reported a profit attributable to owners of the company of HKD 8,225,000, compared to HKD 8,161,000 for the same period in 2020, reflecting a slight increase[34] - The company recorded a basic loss per share of HKD (1,128) for the three months ended December 31, 2021, compared to a profit of HKD 10,316,000 for the same period in 2020[34] Costs and Expenses - The cost of materials and consumables used for the three months ended December 31, 2021, was HKD (10,878,000), an increase from HKD (9,438,000) in the same period of 2020[5] - Employee costs for the three months ended December 31, 2021, were HKD (8,264,000), a decrease from HKD (8,727,000) in the same period of 2020[5] - Depreciation for the three months ended December 31, 2021, was HKD (3,787,000), down from HKD (5,398,000) in the same period of 2020[5] - Other income for the nine months ended December 31, 2021, was HKD 480,000, a decrease of 96.4% from HKD 13,385,000 in the same period of 2020[21] - Employee costs for the nine months ended December 31, 2021, were HKD 26,039,000, down 16.5% from HKD 31,017,000 in the same period of 2020[27] - Depreciation expenses decreased to approximately HKD 12.2 million from HKD 19.9 million, mainly due to a reduction in the number of restaurants[50] - Rental expenses increased by approximately 12.2% to HKD 3.1 million, attributed to costs associated with the pharmaceutical machine business[52] Corporate Actions and Governance - The company has not recommended any dividends for the nine months ended December 31, 2021, consistent with the previous year[33] - The company adopted new and revised Hong Kong Financial Reporting Standards, which did not have a significant impact on the financial data presented[15] - The company has no significant foreign exchange risk as of December 31, 2021, and does not employ hedging measures[62] - As of December 31, 2021, the company has no outstanding capital commitments[63] - There are no significant contingent liabilities reported as of December 31, 2021[64] - The company completed the sale of a 50% stake in a joint venture primarily engaged in cold storage on August 30, 2021[66] - There were no major investments, acquisitions, or disposals of subsidiaries during the nine months ended December 31, 2021[66] - The company did not purchase, sell, or redeem any of its listed securities during the nine months ended December 31, 2021[67] - Major shareholders include MJL, which holds a 50% stake in the company, with significant individual holdings by directors[71] - The company has adopted the corporate governance code as per GEM Listing Rules Appendix 15 and has complied with all applicable provisions during the nine months ended December 31, 2021[80] - The audit committee has reviewed the financial information of the group and believes it complies with applicable accounting standards and GEM Listing Rules, ensuring adequate disclosure[83] Future Outlook and Strategies - The company anticipates that the future performance of its restaurant business will improve once the COVID-19 situation is under control, despite current uncertainties[39] - The company has implemented cost-saving measures, including reducing restaurant staff and negotiating rent discounts with landlords[39] - The company has expanded its business in China by acquiring an automatic vending machine business for HKD 58,000,000, aiming to enhance healthcare service accessibility[41] - The company plans to continue monitoring the performance of its vending machine business and explore opportunities in other major cities in China[37] - The Hong Kong government has announced a relief fund of HKD 3.57 billion to assist businesses affected by tightened social distancing measures, with HKD 1.76 billion specifically for the restaurant industry[36] - The company is focusing on expanding its takeaway product lines and increasing marketing efforts to stimulate sales[39]
倩碧控股(08367) - 2022 Q3 - 季度财报